Clinical Trial Update: Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating retreatment with high-dose pegylated interferon alfa-2a and ribavirin in previous nonresponder HIV-coinfected pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Sociedad Andaluza de Enfermedades Infecciosas | Conditions: Liver Cirrhosis, Hepatitis C Virus | Phase 2, Phase 3 | Status: COMPLETED